A review on the factors influencing the attendance of postpartum diabetes screening for mothers with gestational diabetes mellitus by Thangarajah, Puganeswary et al.
Mal J Med Health Sci 15(SP3): 84-88, Nov 2019 84
Malaysian Journal of Medicine and Health Sciences (eISSN 2636-9346)
REVIEW ARTICLE
A Review on the Factors Influencing the Attendance of 
Postpartum Diabetes Screening for Mothers with Gestational 
Diabetes Mellitus  
Puganeswary Thangarajah, Halimatus Sakdiah Minhat, Nor Afiah Mohd Zulkefli, Norliza Ahmad 
Department of Community Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, 
Selangor, Malaysia
ABSTRACT
Women with gestational diabetes mellitus (GDM) during their pregnancy have a greater risk of developing overt 
diabetes mellitus and dysglycemia (prediabetes, impaired glucose tolerance or impaired fasting glucose) later in 
future, compared to mothers with normal pregnancy.  Postpartum screening is crucial for early identification of type 
2 diabetes (T2DM) in women with GDM. Nevertheless, despite various strategies, its rate remains low. A systematic 
review using databases of PubMed/Medline, Science Direct and CINAHL from 2008 to 2018, was conducted to iden-
tify the factors influencing the attendance of postpartum diabetes screening. Open access English articles, focusing 
on observational studies were reviewed. Primary screening of titles and abstracts of 91 articles were done, secondary 
screening of 31 articles resulted in 6 articles, included in this manuscript. Various factors identified to be associated 
with the attendance to postpartum diabetes screening, which are age, education, ethnicity, some obstetric factors like 
multiparty, and history of insulin usage previously. Many women fail to be screened for diabetes during the postpar-
tum period, and this delays T2DM diagnosis, which in turn gives rise to various complications. Further research that 
considers these factors is necessary for developing interventions to improve postpartum T2DM screening for mothers 
with GDM during their pregnancy
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INTRODUCTION
Gestational Diabetes Mellitus (GDM) is diagnosed during 
the late second or early third trimester of pregnancy that 
is associated with Type 2 Diabetes Mellitus (T2DM). The 
condition is caused by dysglycaemia as articulated by 
the American Diabetes Association (ADA) Standards of 
Diabetes Care 2017 (1). GDM is a potential risk factor 
for the development of T2DM during the postpartum 
period. In particular, patients with GDM normally 
develop T2DM after a period of 5 to 10 years (2, 3). The 
time taken for the patients diagnosed with GDM to show 
T2DM is influenced by the population studied (4) and 
the screening methods employed for a particular study 
(5). The level of glucose tolerance varies from 11% to 
42% for T2DM patients and impaired fasting glycaemia 
respectively (6).
GDM has been perceived as a complication of pregnancy 
that will resolve after childbirth. However, studies have 
established that this diagnosis may imply a lifetime 
of health problems (3, 7, 8). Women with gestational 
diabetes are at increased risk of some complications 
during pregnancy and delivery, as are their infants. GDM 
is associated with an up to a seven-fold increase in the 
risk of manifest T2DM compared with normoglycemic 
pregnancies (3, 9). Studies show that achieving 
glycaemic control with lifestyle modifications and/or 
pharmaceutical intervention during pregnancy prevents 
or considerably reduces the risk of adverse pregnancy 
outcomes (10,11). 
Screening for T2DM is important to identify the diabetic 
status of postpartum mothers. The main reasons for 
the screening for type 2 diabetes are, that there is an 
asymptomatic period in which the condition can be 
detected (12, 13), a substantial proportion of people with 
T2DM are undiagnosed, the seriousness of the immediate 
effects and long-term complications of type 2 diabetes 
and the rising prevalence of type 2 diabetes worldwide 
(14). In Malaysia, the postpartum screening for T2DM 
for a mother who had GDM during her antenatal period 
is performed with a Modified Oral Glucose Tolerance 
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Test (MGTT) between 6 to 8 weeks postpartum.  The 
postpartum T2DM screening is considered as one of the 
golden opportunity to detect and diagnose this disease 
among women because GDM presents women and their 
providers with an impressive opportunity for prevention 
of a major cause of chronic illness and disability among 
long, latent mid-life and older women (15). 
GDM is a risk factor for T2DM (16) and the postpartum 
screening provides a route for assessing the women who 
could benefit when subjected to preventive measures 
(1). Various guidelines available for postpartum T2DM 
screening, however, the rates of postpartum screening 
among women with a history of GDM are low; only half 
of the women in most populations are screened (17). 
This study was aimed to identify the factors influencing 
the attendance of postpartum diabetes screening.
 
MATERIALS AND METHODS
A systematic review was conducted for this study. The 
databases that were included in the search are PubMed/
Medline, Science Direct and CINAHL from 2008 to 2018, 
using following keywords factors, predictor, determinant, 
postpartum, after delivery, diabetes screening, diabetes 
follow-up, diabetes testing, attendance, adherence, and 
non-adherence. The search was limited to open access 
English articles that were focused on observational 
studies, mainly. The articles, which were excluded 
for review, were systematic reviews, review articles, 
technical reports, and meta-analysis. The search was 
conducted electronically according to the Preferred 
Reporting Items for Systematic reviews and Meta-
Analyses (PRISMA) guidelines (18). Figure1 describes 
the flow diagram for the study selection. The quality 
of the articles reviewed was controlled based on the 
STROBE (Strengthening the Reporting of Observational 
Studies in Epidemiology) statement.
RESULTS
The six final articles that were reviewed revealed the 
factors that influence the attendance of postpartum 
diabetes screening. The identified factors are socio-
demographic factors, socio-economic factors, obstetric 
factors, and health system factors. The results are shown 
in Table I and Table II.  The summary of the factors 
influencing the attendance of postpartum diabetes 
screening.in illustrated in Table III.
Figure 1: PRISMA flow diagram of the review
Table I: Factors influencing the non-adherence to Postpartum Screen-
ing
Author/
Year/ 
Country
Study Design/ 
Sample Size/
Participant
Tools Postpartum 
T2DM screen-
ing 
Findings
McGov-
ern et al., 
2014
England
Quantitative ret-
rospective cohort 
study involving 
127 primary care 
practices across 
England were used 
to identify and 
follow-up females 
with GDM. There 
were 1667 women 
involved in this 
study.
Electronic 
general 
practice 
records
OGTT at 
postpartum 6 to 
12weeks
Non-Asian women 
were less likely to 
get tested 
McClo-
skey, 
Bernstein, 
Winter, 
Iverson & 
Lee-Par-
ritz., 
(2014)
US
A retrospective 
cross-sectional 
study of 415 
women who had 
a diagnosis of 
GDM and gave 
birth at Boston 
Medical Center 
(BMC) during a 
6- year period 
(2003–2009).
Profoma on 
Clinical and 
administra-
tive data
OGTT within 
10weeks of 
postpartum
Women aged 
≥35 years of age  
and women that 
had her prenatal 
follow-ups with a 
family medicine 
provider were 
significantly less 
likely to be tested 
Morrison, 
Collins, 
& Lowe., 
(2009)
Australia
Cross-sectional 
study involving 
1372 women 
diagnosed with 
GDM between 
2003 and 2005, 
sampled from the 
National Diabetes 
Services Scheme 
database
Self-admin-
istered ques-
tionnaire
OGTT at 
postpartum 6 to 
8 weeks
Increasing 
age (five years 
increment) was 
associated with a 
lower likelihood 
of returning for 
postnatal testing 
DISCUSSION
Summary of Main Results
This study was aimed to identify the factors influencing the 
attendance of postpartum diabetes screening. Different 
factors were established that influences the attendance 
of postpartum diabetes screening. For instance, a study 
by McCloskey et al (19), established that non-adherence 
was attributed to lack of awareness and some missed 
management by the family medicine practitioners during 
the prenatal follow-ups. These results generally show 
that the adherence to postpartum diabetes screening is 
very low despite having guidelines in place in clinical 
settings. However, studies showed that non-adherence 
decreases when an active search is conducted. To 
illustrate this, women who began postpartum visits 
showed increased adherence compared to those who 
do not attend the visits (20).
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also seem to be a factor, whereby Asians were more 
adhering towards the screening (20, 22) compared to 
other included ethnicities.  
Furthermore, studies had also revealed some obstetrics, 
especially multiparity, previous history of GDM, 
history of insulin usage during pregnancy, history of 
having a Caesarian section as the mode of delivery, 
as contributing factors towards non-adherence to 
postpartum diabetes screening (20, 23, 24). Various 
studies had also discovered that issues related to 
healthcare system influence patients’ adherence 
towards postpartum diabetes screening. Issues such as 
not having any postpartum visits, lack of advice on risk 
reduction, absence of written information after the birth, 
not being under the care of an endocrinologist and also, 
not seen by an obstetrician and diabetes educator during 
GDM pregnancy are among that healthcare system-
related factors that contribute to non-adherence towards 
postpartum diabetes screening.(19 - 21).
Overall Completeness and Applicability of Evidence
This review aimed to synthesize the factors associated 
with non-adherence to postpartum diabetes screening. 
The overall samples that were included in these 
reviewed studies were 16933 women with GDM. 
However, the available evidence was limited, and all 
6 included studies were conducted in a high-income 
country.  This limits the applicability of the evidence to 
low- and middle-income country. As this topic is specific 
to mothers with gestational diabetes, the studies have 
only included this population as their study population, 
however, the applicability is mainly to the high-income 
countries.
This review had considered observational studies designs 
for inclusion and is based on comprehensive searches. 
Table II: Factors influencing the adherence to Postpartum Screening
Author/
Year/ 
Country
Study Design/ 
Sample Size/
Participant
Tools Postpartum 
T2DM screen-
ing
Findings
Lawrence, 
Black, 
Hsu, Chen 
& Sacks, 
(2010).
US
Retrospec-
tive study of 
11,825 wom-
en who were 
identified as 
having GDM 
using the 100-
g oral glucose 
tolerance 
test (OGTT) 
from1999 to 
2006.
Test 
results from 
laboratory 
databases 
and delivery 
details from 
medical 
records
OGTT within 
6 months after 
delivery
Odds of testing 
were independently 
associated with 
Women age 35 to 
39, an Asian/Pacific 
Islander, women 
with high school 
graduate, women 
with high household 
income, women that 
were born Outside 
U.S, and  women 
with only 1 child 
Stasenko, 
Cheng, 
McLean, 
Jelin, 
Rand, & 
Caughey, 
(2010)
US
Retrospective 
cohort study 
involving 745 
women with 
GDM who 
delivered at 
the University 
of California, 
San Francisco 
(UCSF) from 
2002 to 2008.
Medical 
records and 
laboratory 
reports
OGTT within 
6 months after 
delivery
Asian race remained 
a statistically signif-
icant predictor for 
having obtained a 
postpartum glucose 
test as compared 
with white women.
Women aged ≥ 
35years, with higher 
level of education 
and with history of 
Insulin use during 
pregnancy were 
more likely to return 
for testing 
Morrison, 
Collins, 
& Lowe., 
(2009)
Australia
Cross-sec-
tional study 
involving 
1372 women 
diagnosed 
with GDM 
between 2003 
and 2005, 
sampled from 
the National 
Diabetes Ser-
vices Scheme 
database
Self-admin-
istered ques-
tionnaire
OGTT at 
postpartum 6 to 
8 weeks
Factors related to 
return for postnatal 
OGTT at six to eight 
weeks post-GDM 
pregnancy was 
receiving health 
professional deliv-
ered risk reduction 
advice, received 
written information 
after the birth , being 
under the care of 
an endocrinologist 
and not tertiary 
educated and seeing 
an obstetrician as 
well as diabetes ed-
ucator during GDM 
pregnancy 
Oza-
Frank, 
(2014)
US
Secondary 
data analysis 
was conduct-
ed using data 
from the 2009 
and 2010 
Pregnancy 
Risk Assess-
ment Moni-
toring System 
from three 
states and one 
city (Colorado, 
Minnesota, 
Utah, and 
New York 
City). The total 
sample size 
of women 
with a history 
of GDM 
surveyed in 
the sample 
was 909. 
Self-admin-
istered ques-
tionnaire
OGTT at post-
partum 6 to 12 
weeks
Women aged 
25–34,with higher 
income and with a 
pre-pregnancy BMI 
classified as obese 
were more likely to 
report postpartum 
testing 
Most of the findings revealed that the mothers from 
younger age group tend to adhere to the postpartum 
diabetes screening, for instance, the study done in 
the US by McCloskey et al (19), it was noticed that 
the mothers from the older age group tend not to get 
tested during their postpartum period. In fact, it was also 
discovered that increasing age (increment of five years) 
was associated with a lower likelihood of returning for 
postnatal testing (21). Lower education level, as well as 
low household income, is also noted to be factors of 
non-adherence towards postpartum diabetes screening 
(20). From the review, it was noticed that ethnicity 
Table III: Summary of factors influencing attendance of postpartum 
diabetes screening
Factors Authors Major findings
Socio-de-
mograph-
ic factors
Lawrence, Black, Hsu, Chen, & Sacks, 
2010; Morrison, Collins, & Lowe., 
2009; Stasenko, Cheng, McLean, Jelin, 
Rand, & Caughey, 2010; McCloskey, 
Bernstein, Winter, Iverson & Lee-Par-
ritz., 2014; McGovern et al., 2014; 
Oza-Frank, 2014 
Age, ethnicity
Socio-eco-
nomic 
factors
Lawrence, Black, Hsu, Chen, & Sacks, 
2010; Stasenko et al, 2010; Oza-Frank, 
2014
Education level, household 
income
Obstetric 
factors
Lawrence, Black, Hsu, Chen, & Sacks, 
2010; Stasenko et al, 2010; Oza-Frank, 
2014
Parity, History of GDM, history 
of insulin use during pregnancy, 
Health 
system 
factors
Lawrence, Black, Hsu, Chen, & Sacks, 
2010; Morrison, Collins, & Lowe., 
2009; McCloskey, Bernstein, Winter, 
Iverson & Lee-Parritz., 2014
Did not have any postpartum 
visits, absence of risk reduction 
advice, never received written 
information after the birth, not 
being under the care of an 
endocrinologist, not seen by an 
obstetrician and diabetes edu-
cator during GDM pregnancy
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However the search was limited to studies conducted in 
English language.
Potential Biases in the Review Process
Firstly, the identification of studies of factors associated 
with non-adherence to postpartum diabetes screening 
electronically was challenging, which could potentially 
be a source of biasness. Additionally, the literature 
included in this review conducted their research in high-
income countries, information, and findings that are 
related to the middle- and low-income countries were 
not included. The socio-demographic status of patients 
in these countries are different and thus could influence 
the rate of adherence differently. Another limitation 
of this review is that unpublished data could not be 
obtained so as to ascertain if indeed the data obtained 
from the published sources were the actual raw data 
obtained from the field. Finally, the study excluded 
other original papers that were not published in English, 
which limits the search. 
CONCLUSION
Various factors were identified which influence 
the women with the history of GDM to attend their 
postpartum diabetes screening. Among those factors, 
maternal age, parity, education status and income 
status were most influential towards the attendance of 
postpartum diabetes screening , despite the importance 
of the screening, there are still many women that 
fail to be screened and this facilitates the delayed 
T2DM diagnosis, which in turn gives rise to various 
complications. By identifying these factors that influence 
postpartum diabetes screening, various interventions 
and programs related to this matter can be designed 
accordingly.  
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